Seeding of pancreatic islets into prevascularized tissue engineering chambers

Area of Science:

• Biomedical Engineering
• Endocrinology
• Transplantation Biology

Background:

• Islet transplantation is a potential treatment for type 1 diabetes.
• Donor shortages and graft rejection limit current islet transplantation success.
• Improved methods are needed to support transplanted islet survival and function.

Purpose of the Study:

• To develop and evaluate a prevascularized tissue engineering chamber for enhanced islet transplantation.
• To assess the impact of prevascularization on islet survival and glycemic control in diabetic mice.

Main Methods:

• Tissue engineering chambers were implanted onto the epigastric pedicle in diabetic mice.
• Islets were transplanted into chambers either immediately or after 21 days of prevascularization.
• Glycemic control was monitored through blood glucose levels and glucose tolerance tests.

Main Results:

• Transplantation into prevascularized chambers significantly reduced blood glucose levels in diabetic mice.
• Improved glycemic control was observed starting from the third week post-transplantation.
• Prevascularization potentiated islet survival and function compared to immediate transplantation.

Conclusions:

• Prevascularization within tissue engineering chambers enhances islet survival and function.
• This novel approach offers a promising strategy for improving islet transplantation efficacy.
• The chamber design facilitates islet seeding, retrieval, and potential transplantation to alternative sites.